The latest from the 24/7 Wall St. homepage feed — newest first.
The metaverse bet has burned roughly $91 billion with no profit date in sight, and that bill keeps growing while AI capex climbs alongside it.
Meta has now lost a cumulative ~$91 billion from Reality Labs. $META https://t.co/43yJU7doRn
Voluntary exits offered to 60,000 workers put a number on the payroll-for-silicon swap funding Microsoft's AI buildout. Watch whether the labor savings land before the datacenter bill does.
BREAKING: Microsoft offering 60,000 employees money to quit, as it transitions spend from humans to datacenters.
You had the best investment of your life and turned it into the worst investment of your life. You are a true regard.
Selling half a six-year Nvidia position for a car converts an unrealized gain into a taxable one, and 771 comments are debating whether borrowing against the shares would have been cheaper. How you fund a windfall purchase decides what you keep.
Yes! I max out my HSA and *never* use it. Saving that money for later in life - when you'll likely have more medical bills - is the best thing you can do.
The thread's advice is unanimous: treat the HSA as the most tax-advantaged retirement account you have, fund it to the max and pay medical bills out of pocket so the balance stays invested. The mistake is spending it down every year and losing decades of untaxed growth.
The front end just backed off its highs, with the 2-year slipping 6 basis points to 4.61% after the Fed held rates steady. That is the part of the curve that reprices first when policy expectations shift, so money market and short-duration bond holders feel it immediately.
The 10-year slipped back below the 5% line, down 7 basis points to 4.98%, the third straight easing that pulls mortgage rates, bank funding costs and long-duration equity valuations with it.
Twenty-six unbroken years of monthly payouts now come with a 6.18% indicated yield, the kind of entry point net lease buyers rarely get. Miss today's ex-date and you wait another month to start collecting.
Vertex Pharmaceuticals closed at $558.88, a fresh 52-week high and 0.16% above the September 3 peak. The $141.7 billion biotech has now reclaimed the top of its range after a two-month stretch spent trading closer to $500.
Regeneron's Q3 earnings beat lifted it to a fresh 52-week high of $927.89, clearing the September 2 peak by 8.9%. That single jump erases months of range-bound trading in the biotech.
Republic Services is at a record-setting $244.04, its second 52-week high in just over a week and 0.88% above the October 22 peak. The $74.8 billion waste hauler has added roughly $35 a share since late September.
Pfizer cleared $30 for the first time in a year, closing at $30.52 and topping its October 22 peak by 0.33%. The $173.9 billion drugmaker was trading near $23 twelve months ago.
Lucid carved out a fresh 52-week low at $3.02, 2.42% below the floor it set on October 19. The EV maker's market cap is down to $1.2 billion.
Lemonade just carved a new 52-week low at $42.94, 0.49% under the floor it set on Oct. 19. That leaves the insurtech down more than half from its $92.06 peak in January, with a $3.3 billion market cap.
A Q3 earnings beat pushed Imperial Oil to $138.10, a fresh 52-week high and 0.53% above the peak set on August 21. The $66.9 billion producer is now clearing the ceiling it has been testing since May.
A second 52-week low in a week at $23.95, 3.83% below the floor set on Oct. 23. The $9.7 billion miner traded above $76 inside the past year, so holders are watching support that no longer exists.
Chevron's Q3 earnings beat pushed it to a fresh 52-week high of $235.52, 0.99% above the record it set just a week ago. The $462 billion oil major keeps clearing its own ceiling.
Air Products just printed a new 52-week high at $316.43, clearing its early July peak by 0.71% and capping a climb off the $231 low set last December.
A new 52-week high at $276.07 for the insurance broker, 1.78% above the August 24 peak and a full recovery from May lows near $196. The $70.8 billion broker is back in price discovery.
Baidu set a new 52-week low at $76.40, 1.04% under the floor it just made on October 23. The search and AI giant is now a $21 billion company, less than half its January peak above $162.
Box notched a second straight 52-week high at $43.45, just 0.25% above yesterday's peak and nearly double the $21.82 low it sat at in late February. The $6.0 billion enterprise software name is now in uncharted territory for the year.
Intel's steep drop and a tech selloff drove the decline, per Yahoo Finance and Kiplinger.
Imperial Oil's Q3 earnings beat drove a 7.63% jump, a rare one-day move for a $66.9 billion producer. Keep an eye on whether the gain holds once the after-hours crowd clears out.
Evernorth Holdings files S-1 for Nasdaq debut as XRPN
Evernorth Holdings just registered for a Nasdaq listing, putting 73.7 million shares on the table with Cohen & Company Securities and Northland Securities running the deal. No price range yet, so the first amended filing is where the valuation gets set.
A 6.69% slide to $8.37 takes another bite out of a company now worth about $300.9 million, and single-digit share prices leave little cushion. Watch whether the $8 handle holds into the next session.